DE69328102D1 - Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren - Google Patents

Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren

Info

Publication number
DE69328102D1
DE69328102D1 DE69328102T DE69328102T DE69328102D1 DE 69328102 D1 DE69328102 D1 DE 69328102D1 DE 69328102 T DE69328102 T DE 69328102T DE 69328102 T DE69328102 T DE 69328102T DE 69328102 D1 DE69328102 D1 DE 69328102D1
Authority
DE
Germany
Prior art keywords
hymenopteres
flighters
poison
medicine
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69328102T
Other languages
English (en)
Other versions
DE69328102T2 (de
Inventor
Michael Hansen
Ole Gyring Nieben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69328102D1 publication Critical patent/DE69328102D1/de
Publication of DE69328102T2 publication Critical patent/DE69328102T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855Proteins from animals other than mammals or birds
    • Y10S530/858Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69328102T 1992-06-24 1993-06-24 Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren Expired - Fee Related DE69328102T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92828A DK82892D0 (da) 1992-06-24 1992-06-24 Anvendelse af braadgifte fra bier og hvepse til fremstilling af laegemidler til behandling af infektioner
PCT/DK1993/000208 WO1994000137A1 (en) 1992-06-24 1993-06-24 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections

Publications (2)

Publication Number Publication Date
DE69328102D1 true DE69328102D1 (de) 2000-04-20
DE69328102T2 DE69328102T2 (de) 2000-11-09

Family

ID=8098009

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328102T Expired - Fee Related DE69328102T2 (de) 1992-06-24 1993-06-24 Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren

Country Status (13)

Country Link
US (2) US5827829A (de)
EP (1) EP0653939B1 (de)
JP (1) JP3631245B2 (de)
AT (1) ATE190492T1 (de)
AU (1) AU4312093A (de)
CA (1) CA2138793C (de)
DE (1) DE69328102T2 (de)
DK (2) DK82892D0 (de)
ES (1) ES2147200T3 (de)
GR (1) GR3033698T3 (de)
NO (1) NO310058B1 (de)
PT (1) PT653939E (de)
WO (1) WO1994000137A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018983A1 (en) * 1997-10-15 1999-04-22 Alk-Abelló A/S Composition and method for treating an encephalomyelopathic, demyelinating or autoimmune disease
US6372471B1 (en) 1998-10-01 2002-04-16 The Rockefeller University Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
US20040081702A1 (en) 2000-04-14 2004-04-29 Kim Christopher M. Bee venom treatment without the sting
JP5358574B2 (ja) * 2007-08-17 2013-12-04 アルション セラピューティクス, インコーポレイテッド 高濃度の局所麻酔薬調合物
US8119694B2 (en) * 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
CN102988263B (zh) * 2012-12-20 2014-08-20 中国科学院南海海洋研究所 一种具有护唇、美唇功效的蜂毒组合物
KR101596344B1 (ko) * 2013-10-30 2016-02-22 주식회사 청진바이오텍 정제봉독을 이용한 동물의 바이러스성 질환의 예방 및/또는 치료용 조성물
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856936A (en) * 1973-05-07 1974-12-24 Schuyler Dev Corp Composition and method for cortisol control
JPS55149214A (en) * 1979-05-10 1980-11-20 Toyama Chem Co Ltd Medical composition consisting of extract from liquid in bee poison gland
US4822608A (en) * 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
AU640611B2 (en) * 1989-04-13 1993-09-02 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
KR970005329B1 (ko) * 1989-12-07 1997-04-15 게에스에프-프로슝첸트룸 퓌르 움벨트 운트 게순드하이트, 게엠베하 포유 동물의 레트로바이러스 감염 치료용 조성물

Also Published As

Publication number Publication date
AU4312093A (en) 1994-01-24
ES2147200T3 (es) 2000-09-01
JPH07508010A (ja) 1995-09-07
EP0653939A1 (de) 1995-05-24
CA2138793A1 (en) 1994-01-06
NO945031L (no) 1994-12-23
US5827829A (en) 1998-10-27
DK0653939T3 (da) 2000-08-28
US5958887A (en) 1999-09-28
WO1994000137A1 (en) 1994-01-06
CA2138793C (en) 2004-03-09
DE69328102T2 (de) 2000-11-09
EP0653939B1 (de) 2000-03-15
NO945031D0 (no) 1994-12-23
JP3631245B2 (ja) 2005-03-23
GR3033698T3 (en) 2000-10-31
ATE190492T1 (de) 2000-04-15
DK82892D0 (da) 1992-06-24
NO310058B1 (no) 2001-05-14
PT653939E (pt) 2000-08-31

Similar Documents

Publication Publication Date Title
ATE227133T1 (de) Verwendung von interferon-alpha 8 subtype zur herstellung von medikamenten zur behandlung von viralinfektionen der leber
ATE225368T1 (de) Verfahren zur reinigung von faktor viii
DE69733826D1 (de) Behandlung von leukocyten durch photopheresis
ATE138575T1 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
KR950700079A (ko) 이식체-대-숙주 질환을 억제하기 위한 인터루킨-10의 용도(Use of interleukin-10 to suppress graft-vs. -host disease)
DK0722344T3 (da) Fremgangsmåde til virusinaktivering i nærvær af en polyether og et middel
DE69328102D1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
DE69610295T2 (de) Von einem retroviralen regulationsprotein abstammende, detoxifierte immunogene, dagegen gerichtete antikörper, verfahren zur deren herstellung und diese immunogene oder antikörper enthaltende, pharmazeutische zusammensetzungen.
ATE189394T1 (de) Methode zur behandlung von viralen infektionen
DE69627526D1 (de) Rekombinantes pockenvirus der infektiösen peritonitis der katze, dessen zusammensetzungen und methoden zur herstellung und verwendung
ATE236926T1 (de) Herstellung von immunglobulin
ATE180277T1 (de) Zur behandlung von tumoren und hiv-infektionen nützliches pflanzliches protein
ATE194076T1 (de) Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE69324345D1 (de) Expression von osteogenem faktor op-1 in mit rekombinantem baculovirus infizierten spodoptera frugiperda-zellen
ATE180672T1 (de) Verfahren zur herstellung von infektionsfreien pharmazeutischen präparaten und/oder nahrungsmitteln aus infektiösem, insbesondere prionen enthaltendem, material
ATE174507T1 (de) Verwendung eines benzimidazolwurmmittels zur behandlung von mikrosporeninfektionen
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE68913212T2 (de) Ein reines faktor i-protein und verfahren zur herstellung.
ATA6188A (de) Verfahren zur herstellung eines insbesondere zur wundheilung oder zur behandlung in der geriatrie verwendbaren wirkstoffes aus saeugetierblut durch papainhydrolyse und ein einen solchen wirkstoff enthaltendes praeparat
ATE184287T1 (de) Derivate von therapeutisch in der blutgerinnungskaskade wirksamen peptiden, verfahren zur herstellung und sie enthaltende pharmazeutische zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee